{"id":"W2971487735","doi":"10.1016/s1474-4422(19)30238-8","title":"Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":279,"is_retracted":false,"has_abstract":false,"ca_institutions":"St. Michael's Hospital; McGill University; University of Toronto; NeuroRx Research (Canada)","funders":"Javna Agencija za Raziskovalno Dejavnost RS; Celgene","keywords":"Medicine; Internal medicine; Population; Clinical endpoint; Placebo; Multiple sclerosis; Clinical trial; Physical therapy; Pathology; Immunology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009015026,0.0002429158,0.001214833,0.0001570702,0.00008090339,0.0000136379,0.0002610899,0.0001370763,0.0000929588],"category_scores_gemma":[0.001908,0.0001709762,0.0001413546,0.0002299273,0.0003615062,0.00007592406,0.0002326608,0.0007084489,0.00002934037],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004718819,"about_ca_system_score_gemma":0.00005089827,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002095402,"about_ca_topic_score_gemma":0.0003012227,"domain_scores_codex":[0.997404,0.0005962081,0.0006001753,0.0004827401,0.0002887898,0.000628105],"domain_scores_gemma":[0.9951751,0.003779155,0.0002052948,0.0006549317,0.00006623688,0.0001192628],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9585663,0.0005304389,0.007645742,0.0000839446,0.0001754363,0.00001578149,0.001108448,0.00008478744,0.01787525,0.0000247845,0.0003206595,0.01356839],"study_design_scores_gemma":[0.9155195,0.006126856,0.06744143,0.0001436927,0.0001139172,0.000006912751,0.0001085474,0.007293336,0.0007424724,0.000005252488,0.002345501,0.0001525922],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895592,0.0008633748,0.00001537421,0.004875475,0.000831303,0.002971154,0.0000325405,0.00004076441,0.0008107661],"genre_scores_gemma":[0.9962626,0.002660622,0.0001300453,0.0004421877,0.0003390086,0.00006064396,0.00001268714,0.00003183317,0.00006035493],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05979569,"threshold_uncertainty_score":0.6972208,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1008831938011834,"score_gpt":0.3344472093053279,"score_spread":0.2335640155041445,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}